Response to Van Koppen et al.
Response to Van Koppen et al.
复制标题
对 Van Koppen 等人的回应
DOI:
10.1097/hjh.0b013e32835fdf99
复制
发表时间:
2013
影响因子:
4.9
通讯作者:
Kramer,ChristopherM
中科院分区:
文献类型:
--
作者:
Keeley,EllenC;Mehrad,Borna;Kramer,ChristopherM
We have read with great expectations the study of Berthold et al.[1] and would like to thank the authors for another interesting analysis on selenium and hypertension. However, in our view, the publication fell short in several respects, that is, the number of selenium biomarkers analyzed, characterization of study participants with respect to reason for hospital admission, information on trace element supplementation, nutrition estimates (as in Germany, dietary selenium intake is dominated by hypertensinogenic nutrition, ie red meat, eggs, milk and so on, but not by fruits or vegetables) and a critical discussion on potential reasons for the unexpected findings presented. What might underlie this uncommon sex-difference in serum selenium concentrations in the patients of the Lipid analytic cologne (LIANCO) cohort, and why do only the LIANCO women display significant interactions? Judging from the interactions between selenium and hypertension, as graphically depicted in Fig. 1, the only obvious and significant effects appear restricted to the small number of women with serum selenium concentrations above 100mg/l, which clearly represent an unusual subgroup of Germans. One wonders about their clinical oddities, health, multivitamin and trace element self-supplementation, and other potential reasons for a relatively high serum selenium status. Surprisingly, for us the data suggest that even in a population with a relative selenium deficiency higher serum selenium concentrations may be associated with higher blood pressure and a higher prevalence of hypertension in women [1]. These findings are thought-provoking and are raising new questions on the safety of selenium supplementation, even in selenium-deficient populations like in Germany [2, 3]. Until now, there was a widespread belief in the scientific community that correcting a selenium deficit in marginally supplied individuals provides health benefits; the study by Berthold et al.[1] implies the opposite with respect to cardiovascular disease. This result is surprising as the majority of published analyses in this respect report a positive correlation or no interaction [1, 4, 5, 7, 8]. For example, Nawrot et al.[5] in 2007 concluded that a relative selenium deficit might constitute an underestimated risk factor for the development of high blood pressure, especially in European men [6], and Lubos et al.[8] reasoned in 2010 that low selenium concentrations were associated with risk of future cardiovascular death in patients with acute coronary syndrome. These findings can only hardly be aligned to the study of Berthold et al.[1].